About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Biomarker Linked to Drug Development for Vascular Complications in Diabetics

by Reshma Anand on January 18, 2016 at 4:05 PM
Font : A-A+

New Biomarker Linked to Drug Development for Vascular Complications in Diabetics

A molecule called pre-kallikrein (PK) could be a target for the vascular complications associated with type 1 diabetes, said researchers from the Medical University of South Carolina (MUSC), the American University of Beirut (AUB), and Case Western Reserve University report. Ayad A. Jaffa, Ph.D., who holds a dual appointment at MUSC and AUB, led the study.

PK has previously been suggested as a marker for diabetic vascular disease of the kidneys, but the new work supports the idea that increased plasma PK levels are an independent risk factor for whole-body diabetic vascular disease, similar to the risks of high triglycerides or high blood pressure in heart disease.

Advertisement


PK is a member of the kallikrein-kinin system, a group of molecules that frequent the walls of blood vessels. In healthy vessels, circulating PK reaches the vessel surface and activates a sequence of molecular signals that travel inward to the inner vessel layers, called the intima-media, causing momentary changes in dilation and tension.

The types of blood vessel malfunction seen in patients with diabetes causes the cells of the intima-media to spread to the surface, allowing PK to contact them directly. This contact closes the circuit of an alternative pathway of chronic inflammation. Scientists who study the kallikrein-kinin system suspect that this chronic inflammation is responsible for the blood vessel thickening observed in diabetic kidney disease, retinopathy, and atherosclerosis.
Advertisement

Jaffa's team wanted to know if these suspicions were relevant to patients. Specifically, are levels of PK in the blood associated with the blood vessel thickening commonly seen in people with type 1 diabetes?

They started by examining patient samples housed at MUSC and collected as part of a multi-center observational study, called the Epidemiology of Diabetes Interventions and Complications, designed to track the complications and progression of vascular disease in hundreds of people with diabetes. They focused on levels of PK in blood samples paired with ultrasounds taken to measure the thickness of the intima-media of their carotid arteries.

Relevance was found: patients with higher levels of PK in their blood do have thicker layers of intima-media in the vasculature of their carotids.

It isn't clear if high levels of PK cause arteries to thicken or if thicker arteries release more PK. In other words, Jaffa's group can't say yet if PK causes vascular disease or not.

Their work, however, is an important first step to developing a treatment for the vascular complications that seem unavoidable for patients with type 1 diabetes. Their next steps involve developing drug candidates to target PK in preclinical experiments. "These preclinical studies not only will give us insights into the involvement of plasma PK in vascular disease," says Jaffa, "but will also contribute to development of novel treatment strategies for diabetic vascular disease."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Get Involved and Stand Up for Human Rights on Human Rights Day 2022
Coronary Artery Bypass Grafting
Macronutrients Calculator for Weight Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Diabetes - Self-Monitoring of Blood Glucose (SMBG) Diabetes and Exercise Signature Drug Toxicity Type 2 Diabetes 

Most Popular on Medindia

Nutam (400mg) (Piracetam) Drug - Food Interactions Find a Hospital Sinopril (2mg) (Lacidipine) The Essence of Yoga Calculate Ideal Weight for Infants Vent Forte (Theophylline) Pregnancy Confirmation Calculator Color Blindness Calculator Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Biomarker Linked to Drug Development for Vascular Complications in Diabetics Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests